Herbicide-tolerant gene and method of using same

By expressing engineered proteins with oxygenase activity in plants, the problem of insufficient tolerance to synthetic hormones and ACCase inhibitors in the prior art has been solved, the resistance spectrum of herbicides has been broadened, and the improvement of the Herbicide tolerance and safety of crops.

WO2024230371A1PCT designated stage expired Publication Date: 2024-11-14QINGDAO KINGAGROOT SEED SCI CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/085723
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-10
Filing Date
2024-04-03
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

Existing genetically modified plants are insufficient tolerate synthetic hormone herbicides and ACCase inhibitor herbicides, it is difficult to effectively control glyphosate-resistant weeds, and it is limited in resistance to pyridyloxy acid herbicides.

Method used

By designing and expressing engineered proteins with oxygenase activity, recombinant DNA molecules introduce heterologous promoters and chloroplast transport peptides into plants to form transgenic plants, and enhance tolerance to synthetic hormones and ACCase inhibitor herbicides and broaden the resistance spectrum.

Benefits of technology

The plants' tolerance to synthetic hormones and ACCase inhibitor herbicides, including pyridyloxy acid herbicides, enhance the resistance of herbicides, improve crop safety and weed control effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024085723_14112024_PF_FP_ABST
    Figure CN2024085723_14112024_PF_FP_ABST
Patent Text Reader

Abstract

Provided is a recombinant DNA molecule encoding an enzyme that degrades a synthetic hormone herbicide and / or an ACCase inhibitor herbicide. Further provided are a transgenic plant, transgenic plant part, seed, cell and plant part containing the recombinant DNA molecule, and a method of using the transgenic plant, transgenic plant part, seed, cell and plant part.
Need to check novelty before this filing date? Find Prior Art

Description

Herbicide tolerance genes and methods of use thereof Technical Field

[0001] The present invention relates generally to the field of biotechnology. More specifically, the present invention relates to recombinant DNA molecules encoding enzymes that degrade synthetic hormones and / or ACCase inhibitor herbicides. The present invention also relates to transgenic plants, parts, seeds, cells, and plant parts containing the recombinant DNA molecules, and methods of using the same. Background Art

[0002] Crop production typically utilizes transgenic traits produced using biotechnology methods. Heterologous genes (also referred to as transgenics) are introduced into plants to produce transgenic traits. The expression of the transgene in plants imparts desired traits to the plants, such as herbicide tolerance. Examples of transgenic herbicide tolerance traits include glyphosate tolerance, glufosinate tolerance, and dicamba tolerance. With the increase of weed species resistant to the most commonly used herbicides, new herbicide tolerance traits are needed in the field. Particularly interesting herbicides are synthetic hormone herbicides. Synthetic hormone herbicides provide control of a range of glyphosate-resistant weeds, thereby producing traits that are particularly useful in crop systems combined with other herbicide tolerance traits that impart these herbicide tolerances.

[0003] The herbicide-eating bacterium Sphingobium herbicidovorans strain MH, isolated from a dichloropropionic acid-degrading soil sample, was identified as being able to cleave the ether bond of various phyenoxyalkanoic acid herbicides, utilizing them as the sole carbon and energy source for growth (HPE Kohler, Journal of Industrial Microbiology & Biotechnology (1999) 23:336-340). The herbicides are catabolized by two different enantioselective α-ketoglutarate-dependent dioxygenases, RdpA (R-2,4-dichloropropionate dioxygenase) and SdpA (S-2,4-dichloropropionate dioxygenase). (A Westendorf, et al., Microbiological Research (2002) 157:317-322; Westendorf, et al., Acta Biotechnologica (2003) 23(1):3-17). RdpA has been isolated from the herbicide-eating Sphingolipid Bacteria (GenBank accession AF516752 (DNA) and AAM90965 (protein)) and Delftia acidovorans (GenBank accession NG_036924 (DNA) and YP_009083283 (protein)) (TA Mueller, et al., Applied and Environmental Microbiology (2004) 70 (10): 6066-6075). RdpA and SdpA genes have been used in plant transformation to confer herbicide tolerance to crops (TR Wright, et al., Proceedings of the National Academy of Sciences USA, (2010) 107 (47): 20240-5). Using protein engineering techniques to improve the activity of the RdpA enzyme to produce proteins for transgenic plants will allow higher herbicide application rates, thereby improving transgenic crop safety and weed control measures.

[0004] Summary of the Invention

[0005] The present invention provides a recombinant DNA molecule comprising a nucleic acid sequence encoding a polypeptide having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98% or at least 99% identity to an amino acid sequence selected from the group consisting of SEQ ID NO: 1, 5, 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57, 61, 65, 69, 73, 77, 81, 85, 89, 93, 97, 101, 105, 109, 113, 117, 121, 125, 129, 133 or 137.

[0006] In one embodiment, the nucleic acid sequence is selected from the group consisting of SEQ ID NO: 2, 3, 4, 6, 7, 8, 10, 11, 12, 14, 15, 16, 18, 19, 20, 22, 23, 24, 26, 27, 28, 30, 31, 32, 34, 35, 36, 38, 39, 40, 42, 43, 44, 46, 47, 48, 50, 51, 52, 54, 55, 56, 58, 59, 60, 62, 63, 64, 66, 67, 68, 70, 71, 72, 74, 75, 76, 78, 79, 80, 82, 83, 84, 86, 87, 88, 90, 91, 92, 94, 95, 96, 98, 99, 100, 102, 103, 104, 106, 107, 108, 110, 111, 112, 114, 115, 116, 118, 119, 120, 122, 123, 124, 126, 127 , 128, 130, 131, 132, 134, 135, 136, 138, 139, 140, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166 or 167, and nucleic acid sequences that encode the same amino acid sequence as the shown sequence due to the degeneracy of the genetic code.

[0007] In a specific embodiment, the recombinant DNA molecule is operably linked to a heterologous promoter that is functional in plant cells.

[0008] In another specific embodiment, the recombinant DNA molecule is further operably linked to a DNA molecule encoding a chloroplast transit peptide.

[0009] The present invention also provides a DNA construct comprising a heterologous promoter functional in plant cells operably linked to the recombinant DNA molecule.

[0010] In a specific embodiment, it further comprises a DNA molecule encoding a chloroplast transit peptide operably linked to the recombinant DNA molecule.

[0011] In another specific embodiment, the DNA construct is present in the genome of the transgenic plant.

[0012] The present invention provides a plant, seed, plant tissue, plant part or cell comprising the recombinant DNA molecule.

[0013] In a specific embodiment, the plant, seed, plant tissue, plant part or cell comprises tolerance to at least one herbicide selected from the group consisting of synthetic hormone herbicides, ACCase inhibitor herbicides.

[0014] The present invention also provides a plant, seed, plant tissue, plant part or cell comprising the DNA construct.

[0015] The present invention also provides a plant, seed, plant tissue, plant part or cell comprising the polypeptide encoded by the recombinant DNA molecule.

[0016] The present invention also provides a polypeptide having at least 98% or at least 99% identity to an amino acid sequence selected from the group consisting of: SEQ ID NO: 1, 5, 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57, 61, 65, 69, 73, 77, 81, 85, 89, 93, 97, 101, 105, 109, 113, 117, 121, 125, 129, 133 or 137.

[0017] In a specific embodiment, the polypeptide has oxygenase activity against at least one herbicide selected from the group consisting of synthetic hormone herbicides and ACCase inhibitor herbicides.

[0018] The present invention also provides a method for conferring herbicide tolerance to a plant, seed, cell or plant part, the method comprising expressing the polypeptide in the plant, seed, cell or plant part.

[0019] In a specific embodiment, the plant, seed, cell or plant part comprises a DNA construct comprising a heterologous promoter functional in plant cells operably linked to a recombinant DNA molecule encoding the polypeptide.

[0020] In another specific embodiment, wherein said plant, seed, cell or plant part comprises tolerance to at least one herbicide selected from the group consisting of: synthetic hormone herbicides, ACCase inhibitor herbicides.

[0021] The present invention also provides a method for producing herbicide-tolerant transgenic plants, which comprises transforming plant cells or tissues with the recombinant DNA molecule or the DNA construct, and regenerating herbicide-tolerant transgenic plants from the transformed plant cells or tissues.

[0022] In one embodiment, the herbicide-tolerant transgenic plant comprises tolerance to at least one herbicide selected from the group consisting of synthetic hormone herbicides and ACCase inhibitor herbicides.

[0023] The present invention also provides a method for controlling weeds in a plant-growing area, the method comprising contacting the plant-growing area including plants or seeds with at least one herbicide selected from the group consisting of synthetic hormone herbicides and ACCase inhibitor herbicides, the plants or seeds comprising the recombinant DNA molecule and being tolerant to the at least one herbicide.

[0024] Compared with the wild-type RdpA protein, the engineered protein of the present invention not only retains the original resistance to synthetic hormone herbicides such as phenoxycarboxylic acids and / or ACCase inhibitor herbicides, but also increases resistance to pyridyloxy acid herbicides, thereby broadening the spectrum of herbicide resistance.

[0025] Detailed Description of the Invention

[0026] The following definitions and methods are provided to better define the present invention and guide those skilled in the art to implement the present invention. Unless otherwise specified, terms should be understood according to conventional usage by those skilled in the relevant art.

[0027] Engineered proteins and recombinant DNA molecules

[0028] The present invention provides novel engineered proteins and recombinant DNA molecules encoding them. As used herein, the term "engineered" refers to non-natural DNA, proteins, or organisms that are not normally found in nature and are produced through human intervention. An "engineered protein" is a protein whose polypeptide sequence is conceived and created in the laboratory using one or more protein engineering techniques, such as protein design using site-directed mutagenesis and directed evolution using random mutagenesis and DNA shuffling. For example, an engineered protein may have one or more deletions, insertions, or substitutions relative to the coding sequence of a wild-type protein, and each deletion, insertion, or substitution may consist of one or more amino acids. Examples of engineered proteins are provided herein as SEQ ID NOs: 1, 5, 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57, 61, 65, 69, 73, 77, 81, 85, 89, 93, 97, 101, 105, 109, 113, 117, 121, 125, 129, 133, and 137.

[0029] The engineered proteins provided herein are enzymes with oxygenase activity. As used herein, the term "oxygenase activity" refers to the ability to oxidize a substrate by transferring oxygen from molecular oxygen to a substrate, byproduct, or intermediate. The oxygenase activity of the engineered proteins provided herein can inactivate one or more of synthetic hormone herbicides and / or ACCase inhibitor herbicides.

[0030] As used herein, "wild-type" means naturally occurring. As used herein, a "wild-type DNA molecule," "wild-type polypeptide," or "wild-type protein" is a naturally occurring DNA molecule, polypeptide, or protein, i.e., a DNA molecule, polypeptide, or protein that pre-exists in nature. The wild-type version of a polypeptide, protein, or DNA molecule is useful for comparison with an engineered protein or gene. The wild-type version of a protein or DNA molecule is useful as a control in an experiment.

[0031] As used herein, "control" means an experimental control designed for comparison purposes. For example, a control plant in a transgenic plant analysis is a plant of the same type as the experimental plant (i.e., the plant being tested) but without the transgenic insert, recombinant DNA molecule, or DNA construct of the experimental plant. An example of a control plant suitable for comparison with transgenic corn plants is non-transgenic LH244 corn (U.S. Patent No. 6,252,148), and an example of a control plant suitable for comparison with transgenic soybean plants is non-transgenic A3555 soybean (U.S. Patent No. 7,700,846).

[0032] As used herein, the term "recombinant" refers to a non-natural DNA, polypeptide or protein that is the result of genetic engineering and therefore not normally found in nature and that is produced by human intervention. A "recombinant DNA molecule" is a DNA molecule that comprises a DNA sequence that is not naturally occurring and is therefore the result of human intervention, such as a DNA molecule that encodes an engineered protein. Another example is a DNA molecule that is composed of a combination of at least two DNA molecules that are heterologous to each other, such as a DNA molecule that encodes a protein and an operably linked heterologous promoter. An example of a recombinant DNA molecule is a DNA molecule that comprises at least one sequence selected from the group consisting of: SEQ ID NO ... NO:2,3,4,6,7,8,10,11,12,14,15,16,18,19,20,22,23,24,26,27,28,30,31,32,34,35,36,38,39,40,42,43,44,46,47,48,50,51, 52, 54, 55, 56, 58, 59, 60, 62, 63, 64, 66, 67, 68, 70, 71, 72, 74, 75, 76, 78, 79, 80, 82, 83, 84, 86, 87, 88, 90, 91, 92, 94, 95, 96, 98, 99, 100, 102, 103, 104, 106, 107, 108, 110, 111, 112, 114, 115, 116, 118, 119, 120, 122, 123, 124, 126, 127, 128, 130, 131, 132, 134, 135, 136, 138, 139, 140, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166 and 167.

[0033] A "recombinant polypeptide" or "recombinant protein" is a polypeptide or protein that comprises an amino acid sequence that does not occur in nature and, thus, is the result of human intervention, eg, an engineered protein.

[0034] The term "transgenic" refers to a DNA molecule that is artificially incorporated into the genome of an organism as a result of human intervention (e.g., by a plant transformation method). As used herein, the term "transgenic" means comprising a transgene, e.g., a "transgenic plant" refers to a plant that comprises a transgene in its genome, and a "transgenic trait" refers to a characteristic or phenotype that is imparted or conferred by the presence of a transgene incorporated into the plant genome. As a result of this genomic alteration, the transgenic plant is a plant that is significantly different from the associated wild-type plant, and a transgenic trait is a trait that is not naturally found in wild-type plants. The transgenic plant of the present invention comprises the recombinant DNA molecules and engineered proteins provided by the present invention.

[0035] As used herein, the term "heterologous" refers to the relationship between two or more substances that are derived from different sources and are therefore not normally related in nature. For example, a recombinant DNA molecule encoding a protein is heterologous with respect to an operably linked promoter if this combination does not normally occur in nature. In addition, a particular recombinant DNA molecule may be heterologous with respect to a cell or organism into which it is inserted when it does not naturally occur in that particular cell or organism.

[0036] As used herein, the term "DNA molecule encoding a protein" or "DNA molecule encoding a polypeptide" refers to a DNA molecule comprising a nucleotide sequence encoding a protein or polypeptide. "Sequence encoding a protein" or "sequence encoding a polypeptide" means a DNA sequence encoding a protein or polypeptide. "Sequence" means the sequential arrangement of nucleotides or amino acids. The boundaries of a sequence encoding a protein or a sequence encoding a polypeptide are generally determined by a translation start codon at the 5' end and a translation stop codon at the 3' end. A molecule encoding a protein or a molecule encoding a polypeptide may comprise a DNA sequence encoding a protein or polypeptide sequence. As used herein, "transgenic expression," "expressing a transgene," "protein expression," "polypeptide expression," "expressing a protein," and "expressing a polypeptide" mean the production of a protein or polypeptide by the process of transcribing a DNA molecule into messenger RNA (mRNA) and translating the mRNA into a polypeptide chain (which can ultimately fold into a protein). A DNA molecule encoding a protein or a DNA molecule encoding a polypeptide can be operably linked to a heterologous promoter in a DNA construct for expression of the protein or polypeptide in cells transformed with the recombinant DNA molecule. As used herein, "operably linked" refers to two DNA molecules that are linked in such a way that one DNA molecule can affect the function of the other DNA molecule. Operably linked DNA molecules can be part of a single continuous molecule and may or may not be adjacent. For example, a promoter is operably linked to a protein-encoding DNA molecule or a polypeptide-encoding DNA molecule in a DNA construct, where the two DNA molecules are arranged so that the promoter can affect the expression of a transgene.

[0037] As used herein, "DNA construct" is a recombinant DNA molecule comprising two or more heterologous DNA sequences. The DNA construct is suitable for transgenic expression and can be included in vectors and plasmids. The DNA construct can be used in a vector for the purpose of transformation (i.e., introducing heterologous DNA into a host cell) to produce transgenic plants and cells, and therefore can also be included in the plasmid DNA or genomic DNA of a transgenic plant, seed, cell or plant part. As used herein, "vector" means any recombinant DNA molecule that can be used for plant transformation purposes. The recombinant DNA molecule as shown in the sequence table can be, for example, inserted into a vector as a part of a construct, wherein the construct has a recombinant DNA molecule operably connected to a promoter, and the promoter works in the plant to drive the expression of the engineered protein encoded by the recombinant DNA molecule. The method for constructing a DNA construct and a vector is well known in the art. The components of a DNA construct or a vector comprising a DNA construct generally include, but are not limited to, one or more of the following: a suitable promoter for expressing the DNA operably connected, a non-human DNA molecule encoding a protein operably connected, and a 3' untranslated region (3'-UTR). Promoters suitable for practicing the present invention include promoters that work in plants to express operably connected polynucleotides. Such promoters are diverse and well known in the art and include inducible, viral, synthetic, constitutive, temporally regulated, spatially regulated and / or spatiotemporally regulated. Additional optional components include, but are not limited to, one or more of the following elements: a 5'-UTR, an enhancer, a leader sequence, a cis-acting element, an intron, a chloroplast transit peptide (CTP), and one or more selectable marker transgenes.

[0038] The DNA construct of the present invention can include a CTP molecule operably connected to the DNA molecule of the protein encoding provided by the invention. Suitable for practicing the CTP of the present invention include those for promoting the intracellular localization of engineered protein molecules. By promoting intracellular protein localization, CTP can increase the accumulation of engineered proteins, protect it from proteolytic degradation, enhance herbicide tolerance level, and thus reduce the damage level after the herbicide is applied. The CTP molecule used for the present invention is known in the art, including but not limited to Arabidopsis EPSPS CTP (Klee et al., 1987), Petunia EPSPS CTP (della-Cioppa et al., 1986), corn cab-m7 signal sequence (Becker et al., 1992; PCT WO 97 / 41228) and pea glutathione reductase signal sequence (Creissen et al., 1991; PCT WO 97 / 41228).

[0039] The recombinant DNA molecules of the present invention can be synthesized and modified in whole or in part by methods known in the art, particularly where it is desired to provide sequences suitable for DNA manipulation (e.g., restriction enzyme recognition sites or recombination-gene cloning sites), plant-preferred sequences (e.g., plant codon usage or Kozak consensus sequences), or sequences suitable for DNA construct design (e.g., spacer or linker sequences). The present invention includes recombinant DNA molecules and engineered proteins having at least about 80% (percentage) sequence identity, about 85% sequence identity, about 90% sequence identity, about 91% sequence identity, about 92% sequence identity, about 93% sequence identity, about 94% sequence identity, about 95% sequence identity, about 96% sequence identity, about 97% sequence identity, about 98% sequence identity, and about 99% sequence identity with any of the recombinant DNA molecules or engineered protein sequences provided herein, for example, with a recombinant DNA molecule comprising a sequence selected from the group consisting of: SEQ ID NO ... NO:2,3,4,6,7,8,10,11,12,14,15,16,18,19,20,22,23,24,26,27,28,30,31,32,34,35,36,38,39,40,42,43,44, 46, 47, 48, 50, 51, 52, 54, 55, 56, 58, 59, 60, 62, 63, 64, 66, 67, 68, 70, 71, 72, 74, 75, 76, 78, 79, 80, 82, 83, 84, 86, 87, 8 8, 90, 91, 92, 94, 95, 96, 98, 99, 100, 102, 103, 104, 106, 107, 108, 110, 111, 112, 114, 115, 116, 118, 119, 120, 122, 123, 124, 126, 127, 128, 130, 131, 132, 134, 135, 136, 138, 139, 140, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166 and 167.

[0040] As used herein, the term "percent sequence identity" or "% sequence identity" refers to the percentage of identical nucleotides or amino acids in the linear polynucleotide or polypeptide sequence of a reference ("query") sequence (or its complementary strand) compared to a test ("subject") sequence (or its complementary strand) when the two sequences are optimally aligned (having appropriate nucleotide or amino acid insertions, deletions, or gaps totaling less than 20% of those of the reference sequence over the comparison window). Optimal sequence alignment for aligning a comparison window is well known to those skilled in the art and can be performed by tools such as the local homology algorithm of Smith and Waterman, the homology alignment algorithm of Needleman and Wunsch, the search for similarity method of Pearson and Lipman, and by computerized implementations of these algorithms, such as the Optimal Alignment Algorithm (AAL) using default parameters. Wisconsin (Accelrys Inc., San Diego, CA), MEGAlign (DNAStar, Inc., 1228 S. Park St., Madison, Wis. 53715), and GAP, BESTFIT, FASTA, and TFASTA are available as part of MUSCLE (version 3.6) (RCEdgar, Nucleic Acids Research (2004) 32(5): 1792-1797). The "identity score" of an aligned segment of a test sequence and a reference sequence is the number of identical components shared by the two aligned sequences divided by the total number of components in the reference sequence segment, i.e., the entire reference sequence or a smaller, defined portion of the reference sequence. Percent sequence identity is expressed as the identity score multiplied by 100. Comparison of one or more sequences can be to the full-length sequence or a portion thereof, or to longer sequences.

[0041] Engineered proteins can be produced by altering (i.e., modifying) wild-type proteins to produce new proteins with novel combinations of useful protein characteristics (e.g., altered Vmax, Km, substrate specificity, substrate selectivity, and protein stability). Modifications can be made at specific amino acid positions in the protein, and can be substitutions of the amino acid found at the position in nature (i.e., in the wild-type protein) with a different amino acid. The amino acid sequence of the wild-type protein RdpA suitable for protein engineering is shown in SEQ ID NO: 1. Design an engineered protein having at least about 92% sequence identity to an amino acid sequence selected from the group consisting of SEQ ID NO: 1, 5, 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57, 61, 65, 69, 73, 77, 81, 85, 89, 93, 97, 101, 105, 109, 113, 117, 121, 125, 129, 133, and 137, and comprising at least one of these amino acid mutations. Thus, the engineered proteins provided herein provide novel proteins having one or more altered protein characteristics relative to wild-type proteins found in nature. In one embodiment of the invention, the engineered protein has altered protein characteristics, such as improved or reduced activity against one or more herbicides or improved protein stability, compared to a similar wild-type protein or any combination of such characteristics. In one embodiment, the present invention provides engineered proteins and recombinant DNA molecules encoding the same having at least about 80% sequence identity, about 85% sequence identity, about 90% sequence identity, about 91% sequence identity, about 92% sequence identity, about 93% sequence identity, about 94% sequence identity, about 95% sequence identity, about 96% sequence identity, about 97% sequence identity, about 98% sequence identity, and about 99% sequence identity to an engineered protein sequence selected from the group consisting of SEQ ID NO: 1, 5, 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57, 61, 65, 69, 73, 77, 81, 85, 89, 93, 97, 101, 105, 109, 113, 117, 121, 125, 129, 133, and 137. Amino acid mutations can be made as single amino acid substitutions in a protein or in combination with one or more other mutations (such as one or more other amino acid substitutions, deletions, or additions). Mutations can be made as described herein or by any other method known to those skilled in the art.

[0042] genetically modified plants

[0043] One aspect of the present invention includes transgenic plant cells, transgenic plant tissues, transgenic plants and transgenic seeds comprising recombinant DNA molecules and engineered proteins provided by the invention. These cells, tissues, plants and seeds comprising recombinant DNA molecules and engineered proteins show herbicide tolerance to one or more of synthetic hormone herbicides, ACCase inhibitor herbicides.

[0044] In fact, the suitable method for transforming the host plant cell for the present invention includes any method that can introduce DNA into cell (for example, wherein the recombinant DNA construct is stably integrated into the plant chromosome) and is known in the art.Exemplary and widely used method for introducing the recombinant DNA construct into plant is Agrobacterium transformation system, which is well known to those skilled in the art.Transgenic plants can be regenerated from the plant cell transformed by the method for plant cell culture.About the transgenic plant homozygous (that is, two allele copies of transgenic) can be by self-pollination (selfing) of the transgenic plant comprising a single transgenic allele and itself (for example R0 plant) to produce R1 seed.One quarter of the R1 seed produced will be homozygous for transgenic.Usually use SNP to measure, DNA sequencing or allow the heat amplification of the difference between heterozygote and homozygote to measure the zygosity of the plant grown from the R1 seed of germination, be called zygosity assay.

[0045] The plants, seeds, plant parts, plant tissues and cells provided by the present invention show herbicide tolerance to one or more of synthetic hormone herbicides and ACCase inhibitor herbicides, and in particular show herbicide tolerance to pyridyloxy acid compounds as shown in Formula I and their salts and ester derivatives.

[0046] In the present invention, "synthetic hormone herbicides" are substances that have herbicidal activity themselves or are used in combination with other herbicides and / or additives that can modify their effects. They are plant hormone-interfering herbicides and are well known in the art. For example, they include at least one of the following active ingredients or their derivatives:

[0047] (1) Pyridine carboxylic acids: amiloride (picloram), fluroxypyr (fluroxypyr), fluroxypyr ethyl ester, amiloride, clopyralid, triclopyr, fluroxypyr ester, fluroxypyr ester, pyridyloxy acid compounds as shown in formula I and their salts and ester derivatives;

[0048] (2) Benzoic acids: dicamba, fenpropimorph, dicamba, naphthamide, etc.

[0049] (3) Phenoxycarboxylic acids: 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4-dichlorophenoxybutyric acid (2,4-D butyric acid), 2,4-D isopropionic acid, chloramic acid, dimethyltetrachlorophenoxy, dimethyltetrachloroisopropionic acid, dimethyltetrachlorobutyric acid, etc.

[0050] (4) Quinoline carboxylic acids: dichloroquinoline, clomaquinoline, etc.

[0051] (5) Others: Herbicide, etc.

[0052] The pyridyloxy acid compound and its salt and ester derivatives as shown in formula I,

[0053] Wherein, A and B independently represent halogen, C1-C6 alkyl, halogenated C1-C6 alkyl, or C3-C6 cycloalkyl;

[0054] C represents hydrogen, halogen, C1-C6 alkyl, halogenated C1-C6 alkyl;

[0055] Q represents C1-C6 alkyl, halogenated C1-C6 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, cyano, amino, nitro, formyl, C1-C6 alkoxy, C1-C6 alkylthio, C1-C6 alkoxycarbonyl, hydroxy C1-C6 alkyl, C1-C6 alkoxy C1-C2 alkyl, cyano C1-C2 alkyl, C1-C6 alkylamino C1-C2 alkyl, benzyl, naphthyl, furyl, thienyl, thiazolyl, pyridyl, pyrimidinyl, and unsubstituted or substituted C1-C6 alkyl Phenyl which is unsubstituted or substituted with at least one of C1-C6 alkyl, halogenated C1-C6 alkyl, halogen and C1-C6 alkoxy;

[0056] Y represents amino, C1-C6 alkylamino, C1-C6 alkylcarbonylamino, phenylcarbonylamino, benzylamino, unsubstituted or halogenated C1-C6 alkyl-substituted furylmethyleneamino;

[0057] The salt is a metal salt, an ammonium salt NH4 + , primary amine salt RNH2, secondary amine salt (R)2NH, tertiary amine salt (R)3N, quaternary amine salt (R)4N + , morpholine salts, piperidine salts, pyridine salts, aminopropylmorpholine salts, Jeff amine D-230 salts, salts of 2,4,6-tris(dimethylaminomethyl)phenol and sodium hydroxide, C1-C14 alkylsulfonium salts, C1-C14 alkylsulfoxide salts, C1-C14 alkylphosphonium salts, C1-C14 alkanolphosphonium salts;

[0058] wherein R each independently represents an unsubstituted C1-C14 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl or phenyl, and the C1-C14 alkyl is optionally substituted with one or more of the following groups: halogen, hydroxy, C1-C6 alkoxy, C1-C6 alkylthio, hydroxy C1-C6 alkoxy, amino, C1-C6 alkylamino, amino C1-C6 alkylamino, phenyl;

[0059] The ester is Wherein, X represents O or S;

[0060] M represents C1-C18 alkyl, halogenated C1-C8 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, halogenated C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkoxy, C1-C6 alkoxycarbonyl, C1-C6 alkylsulfonyl, cyano C1-C2 alkyl, nitro C1-C2 alkyl, C1-C6 alkoxy C1-C2 alkyl, C1-C6 alkoxycarbonyl C1-C2 alkyl, C2-C6 alkenyloxycarbonyl C1-C2 alkyl, -(C1-C2 alkyl)-Z, Tetrahydrofuranyl, pyridyl, naphthyl, furanyl, thienyl, and unsubstituted or C1-C6 alkyl-substituted Phenyl which is unsubstituted or substituted by C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkylamino, halogen or C1-C6 alkoxy;

[0061] Z stands for Tetrahydrofuranyl, pyridyl, Thiphenyl, furyl, naphthyl, and phenyl which is unsubstituted or substituted with at least one of C1-C6 alkyl, C1-C6 alkoxy, halogenated C1-C6 alkyl, cyano, and halogen;

[0062] R3 each independently represents a C1-C6 alkyl group;

[0063] R4, R5, and R6 independently represent hydrogen, C1-C6 alkyl, or C1-C6 alkoxycarbonyl;

[0064] R' represents hydrogen, C1-C6 alkyl, or halogenated C1-C6 alkyl.

[0065] In one embodiment, the compounds of the general formula I and I-1 are both in R configuration (the carbon atom at the * is a chiral center). In another embodiment, in the compound of the general formula I, A represents chlorine, B represents chlorine, C represents fluorine, Y represents amino, Q represents methyl, and is in R configuration (the carbon atom at the * is a chiral center) (i.e., compound A); in the compound of the general formula I-1, A represents chlorine, B represents chlorine, C represents fluorine, Y represents amino, Q represents methyl, X represents O, and M represents methyl, and is in R configuration (the carbon atom at the * is a chiral center) (i.e., compound B); or in the compound of the general formula I-1, A represents chlorine, B represents chlorine, C represents fluorine, Y represents amino, Q represents methyl, X represents O, and M represents tetrahydrofuran-2-ylmethyl And it is of R configuration (i.e. compound C) (the carbon atom at * is the chiral center).

[0066] In the present invention, "ACCase inhibitor herbicides" refer to herbicides that target acetyl-CoA carboxylase, which are well known in the art and include, for example, at least one of the following active ingredients or their derivatives:

[0067] (1) Aryloxyphenoxypropionic acid: quizalofop-p-butyl, clodinafop-butyl, cyhalofop-butyl, diclofop-butyl, fenoxaprop-butyl, fluazifop-butyl, fluazifop-butyl, methicillin, oxadiazol-butyl, quinacral, etc.

[0068] (2) Cyclohexenone: fenpropimorph, clethodim, cyclohexanone, butyclodim, cypermethrin, sethoxydim, pyraclostrobin, trimethylolpropane, etc.

[0069] (3) Benzopyridines: pinoxazoline, etc.

[0070] In the context of this specification, if the abbreviation of the common name of the active compound is used, all conventional derivatives, such as esters and salts, as well as isomers, in particular optical isomers, in particular one or more commercially available forms, are included in each case. If the common name designates an ester or salt, all other conventional derivatives, such as other esters and salts, free acids and neutral compounds, as well as isomers, in particular optical isomers, in particular one or more commercially available forms, are also included in each case. The chemical name of a compound given indicates at least one compound encompassed by the common name, generally the preferred compound. For example, 2,4-D or 2,4-D butyric acid derivatives include but are not limited to: 2,4-D or 2,4-D butyric acid salts such as sodium salt, potassium salt, dimethylammonium salt, triethanolammonium salt, isopropylamine salt, choline, etc., and 2,4-D or 2,4-D butyric acid esters such as methyl ester, ethyl ester, butyl ester, isooctyl ester, etc.; dimethyltetrachloro derivatives include but are not limited to: dimethyltetrachloro sodium salt, potassium salt, dimethylammonium salt, isopropylamine salt, etc., and dimethyltetrachloromethyl ester, ethyl ester, isooctyl ester, ethylthioester, etc.

[0071] Herbicides can be applied to a plant growth area containing the plants and seeds provided herein as a method of controlling weeds. The plants and seeds provided herein contain a herbicide tolerance trait and are therefore tolerant to the application of one or more synthetic hormone herbicides, ACCase inhibitor herbicides. When applying the herbicide, the plant growth area may or may not contain weedy plants.

[0072] Herbicide applications can be sequentially tank-mixed with one, two, or a combination of several synthetic hormone herbicides, ACCase inhibitor herbicides, or any other compatible herbicides. Multiple applications of one herbicide or a combination of two or more herbicides, or alone, can be applied to an area containing transgenic plants of the present invention during the growing season for controlling a broad spectrum of dicotyledonous weeds, monocotyledonous weeds, or both, for example, two applications (e.g., pre-planting application and post-emergence application or pre-emergence application and post-emergence application) or three applications (e.g., pre-planting application, pre-emergence application, and post-emergence application or pre-emergence application and two post-emergence applications).

[0073] As used herein, "resistance," "herbicide resistance," "tolerance," or "herbicide tolerance" refers to the ability of a plant, seed, plant tissue, plant part, or cell to resist the toxic effects of one or more herbicides. The herbicide tolerance of a plant, seed, plant tissue, plant part, or cell can be measured by comparing the plant, seed, plant tissue, plant part, or cell to a suitable control. For example, herbicide tolerance can be measured by applying a herbicide to a plant comprising a recombinant DNA molecule encoding a protein capable of conferring herbicide tolerance (a test plant) and a plant not comprising a recombinant DNA molecule encoding a protein capable of conferring herbicide tolerance (a control plant), and then comparing plant damage to the two plants, wherein the herbicide tolerance of the test plant is indicated by a reduced damage rate compared to the damage rate of the control plant. When compared to a control plant, seed, plant tissue, plant part, or cell, a herbicide-tolerant plant, seed, plant tissue, plant part, or cell exhibits a reduced response to the toxic effects of the herbicide. As used herein, a "herbicide tolerance trait" is a transgenic trait that confers improved herbicide tolerance to a plant compared to wild-type plants or control plants.

[0074] Transgenic plant of the present invention, filial generation, seed, vegetable cell and plant part also can contain one or more other transgenic proterties.Can introduce other transgenic proterties by making the transgenic plant that contains the recombinant DNA molecule provided by the invention and another kind of plant hybridization that contains other transgenic proterties.As used herein, " hybridization " means to cultivate two independent plants to produce progeny plant.Therefore, two transgenic plants can hybridize to produce the progeny that contains transgenic proterties.As used herein, " filial generation " means the offspring of any going down to posterity of parental plant, and the transgenic progeny comprises provided by the present invention and from the DNA construct of at least a parental plant inheritance.Perhaps, can by with the DNA construct that comprises recombinant DNA molecule provided by the invention cotransformation described in other transgenic proterties DNA construct (for example, wherein all DNA constructs are presented as the part of the same carrier that is used for plant transformation) or by by other proterties inserting in the transgenic plant that comprises DNA construct provided by the invention or vice versa (for example, by using any method about plant transformation of transgenic plant or vegetable cell) introduce other transgenic proterties. Such additional transgenic traits include, but are not limited to, increased insect resistance, increased water use efficiency, increased yield performance, increased drought resistance, increased seed quality, improved nutritional quality, hybrid seed production, and herbicide tolerance, wherein the traits are measured relative to wild-type plants or control plants. Such additional transgenic traits are known to those skilled in the art; for example, the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) provides a list of such traits and can be found on their website www.aphis.usda.gov.

[0075] Transgenic plants and progeny containing transgenic traits provided by the invention can be used together with any breeding method generally known in the art. In the plant system comprising two or more transgenic traits, transgenic traits can be separated, connected or a combination of the two independently in the plant system comprising three or more transgenic traits. Backcrossing with the parent plant and outcrossing with non-transgenic plants, and asexual reproduction are also considered. The description of the breeding method generally used for different traits and crops is well known to those skilled in the art. In order to confirm the existence of transgenic in specific plants or seeds, multiple determinations can be carried out. This type of determination includes for example molecular biology determinations, such as southern blotting and northern blotting, PCR and DNA sequencing; Biochemical determinations, such as for example by immunological methods (ELISA and Western blotting) or by the existence of enzyme function detection protein products; Plant part determinations, such as leaf or root determinations; And also by analyzing the phenotype of whole plant.

[0076] Introgression of a transgenic trait into a plant genotype is achieved as a result of a backcross transformation process. A plant genotype into which the transgenic trait has been introgressed can be referred to as a backcross transformed genotype, line, inbred plant, or hybrid. Similarly, a plant genotype lacking the desired transgenic trait can be referred to as an untransformed genotype, line, inbred plant, or hybrid.

[0077] As used herein, the term "comprising" means "including but not limited to". BRIEF DESCRIPTION OF THE DRAWINGS

[0078] Figure 1. Reaction rate determination results of some engineered proteins towards 2,4-D.

[0079] FIG2 shows the effect of treating T0 transgenic corn plants expressing M7 protein with 10 g / mu of compound C.

[0080] Figure 3 shows the effect of treating T1 transgenic corn plants expressing M1, M7, M11, M12, M13, M14, M16, M18, M19, M23, M24, M25, and M26 proteins with 150 g / mu of compound C.

[0081] FIG4 shows the effect of treating T1 transgenic soybean plants expressing M19 and M13 proteins with 10 g / mu of Compound C.

[0082] Sequence Description DETAILED DESCRIPTION

[0083] Example 1. Initial protein engineering and enzyme analysis

[0084] The RdpA protein sequence was blasted against the NCBI database. Nine protein sequences with varying degrees of sequence similarity were selected from the resulting output. Combining the sequence alignment results, RdpA was recombined with large fragments of protein sequences from various sources using methods such as Golden Gate Shuffling. This generated over 8,700 unique engineered proteins and recombinant DNA molecules encoding them for further analysis and characterization. Due to the need to test a large number of engineered proteins and to test and compare the enzymatic activity of each protein, a high-throughput bacterial protein expression and screening system was developed for rapid analysis using crude bacterial products.

[0085] The gene encoding each engineered protein is cloned into a bacterial expression vector containing a histidine tag (His-tag) at the C-terminus to achieve high-throughput protein expression. The vector is transformed into Escherichia coli (E.coli), and bacterial expression of the engineered protein is induced. Escherichia coli cultures are selected and cultured overnight in centrifuge tubes, and substrate and IPTG are added at the same time, or only substrate is added, and the culture is centrifuged the next day to precipitate the bacteria. Alternatively, Escherichia coli cultures are selected and cultured overnight in centrifuge tubes, and the substrate is added and centrifuged after the reaction the next day to precipitate the bacteria. The supernatant of the reaction solution is drawn into a 96-well plate and the phenol product is detected by end-point colorimetric measurement of the absorbance at 510 nm from 4-aminoantipyrine and potassium ferricyanide, and the oxygenase activity (i.e., its enzymatic activity) of the engineered protein is measured by high-performance liquid chromatography to detect the substrate reduction and product production. The activity of the protein is compared by calculating the conversion rate, and some of the results are shown in Table 1.

[0086] Conversion rate = (initial substrate peak area - post-reaction substrate peak area) / initial substrate peak area * 100%

[0087] Table 1. Transformation efficiency of various mutants Note: Reaction condition 1: Culture bacteria overnight and add substrate compound A and IPTG to react overnight;

[0088] Reaction condition 2: Culture the bacteria overnight and add 8 times the dose of substrate compound A in reaction condition 1 and react overnight;

[0089] Reaction condition 3: Culture the bacteria overnight, and on the second day add 8 times the dose of substrate compound A in reaction condition 1 and react for 1 hour.

[0090] Based on the results of the high-throughput liquid phase assay system, representative engineered proteins were selected for protein purification. Further protein characterization, such as Km, Vmax, and Kcat, was performed using the 33 engineered proteins from Table 2. Protein purification used conventional Ni column affinity chromatography. The purity of the protein extract was assessed by SDS-PAGE analysis. The protein concentration was determined by the BCA method and then the enzyme activity was measured. The control was the purified wild-type enzyme. The protein enzyme kinetics were measured using 0, 10, 20, 50, 100, 200, 500, and 1000 uM of Compound A.

[0091] Table 2. Test results of engineered proteins Note: N / D means the enzyme activity is too low to determine its enzyme kinetic parameters.

[0092] Table 2 shows the Km, Vmax, Kcat, and Kcat / Km measured for 33 proteins with Compound A as substrate. The enzyme kinetic parameters of these 33 engineered proteins indicate that the enzyme activity, i.e., Km and Kcat, of proteins can be significantly improved through protein engineering.

[0093] In addition, the catalytic activity towards 2,4-DP / 2,4-D was determined using the same method as above, and some representative data are shown in Table 3 and Figure 1 .

[0094] Table 3. Results of enzyme activity assays of some engineered proteins against 2,4-DP (2,4-D-isopropionate)

[0095] Table 3 shows the Km, Vmax, Kcat, and Kcat / Km measured for the four proteins with compound 2,4-DP as substrate. The enzyme kinetic parameters of these four engineered proteins indicate that the tested engineered proteins maintain or even significantly improve their activity towards 2,4-DP compared to the wild-type RdpA enzyme.

[0096] Figure 1 shows the maximum reaction rates (in abs / 1000 min) measured for 19 proteins using compound 2,4-D as a substrate. The reaction rates of these 19 engineered proteins indicate that the 2,4-D activity of the tested engineered proteins is maintained or even significantly improved compared to the wild-type RdpA enzyme.

[0097] Example 2: Expression of engineered proteins in corn

[0098] Engineered proteins were selected for maize transformation and in planta analysis. DNA constructs were transformed into maize using Agrobacterium tumefaciens using standard methods known in the art.

[0099] Transgenic plantlets of the T0 generation expressing the engineered protein and non-transgenic recipient plants were cultured in a greenhouse. T0 transgenic plantlets and wild-type corn plants were sprayed with 10 g / mu of Compound C under strict control conditions and tested. As shown in Figure 2, the wild-type showed obvious phytotoxicity, while transgenic plantlets containing the M7 protein encoding gene grew normally. In addition, T0 transgenic plantlets expressing other engineered proteins of the present invention (such as M1, M11, M12, M13, M14, M16, M18, M19, M23, M24, M25, and M26) also grew normally. This shows that transgenic corn containing the engineered protein encoding gene of the present invention has better drug resistance than wild-type corn under 10 g / mu Compound C treatment conditions.

[0100] The T0 transgenic resistant plants, after spraying, were grown in a greenhouse, and T1 corn seeds produced from all T0 transgenic resistant plants were collected. The T1 seeds were sown and sprayed with 0, 90, 120, and 150 g / mu of Compound C at the approximately two-leaf, one-heart stage. The resistance of the plants was assessed after each treatment. After application of 150 g / mu of Compound C (11 days after treatment), transgenic corn plants containing the gene encoding the engineered protein of the present invention exhibited superior resistance compared to wild-type plants, indicating that T1 transgenic corn plants expressing the engineered protein tolerate a dose of at least 150 g / mu of Compound C. Representative test results are shown in Figure 3.

[0101] Example 3: Expression of engineered proteins in soybeans

[0102] Engineered proteins were selected for soybean transformation and plant analysis.DNA constructs were transformed into soybean using Agrobacterium tumefaciens using standard methods known in the art.

[0103] The transformed T0 transgenic plantlets were grown in a greenhouse, and T1 seeds from the transgenic plantlets that were positive were collected. T1 seeds were sown, and the T1 plantlets were sprayed with 10g / mu of Compound C. The resistance of the plants was recorded and evaluated 12 days after the spraying treatment. Compared to wild-type plants that were unable to survive due to severe drug damage, transgenic soybean plants containing genes encoding the engineered proteins described in the present invention (such as M13, M16, M19, M23, and M24) showed superior drug resistance. Representative test results are shown in Figure 4.

[0104] Numerous tests have also revealed that the introduction of the recombinant DNA molecules described herein into model plants, such as Arabidopsis thaliana and Brachypodium distachyon, resulted in correspondingly enhanced resistance to synthetic hormone herbicides and / or ACCase inhibitor herbicides. This suggests that the transgenic introduction of these molecules into other plants, such as grain crops, legumes, oilseed crops, fiber crops, fruit crops, root crops, vegetable crops, flower crops, medicinal crops, feedstock crops, forage crops, sugar crops, beverage crops, lawn plants, tree crops, and nut crops, could also produce corresponding resistance traits, demonstrating significant industrial value.

[0105] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and are not limiting. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solutions of the present invention may be modified or replaced by equivalents without departing from the spirit and scope of the technical solutions of the present invention.

Claims

1. A recombinant DNA molecule comprising a nucleic acid sequence encoding a polypeptide having at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98% or at least 99% identity to an amino acid sequence selected from the group consisting of SEQ ID NO: 1, 5, 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57, 61, 65, 69, 73, 77, 81, 85, 89, 93, 97, 101, 105, 109, 113, 117, 121, 125, 129, 133 or 137.

2. The recombinant DNA molecule of claim 1, wherein the nucleic acid sequence is selected from the group consisting of: SEQ ID NO: 2, 3, 4, 6, 7, 8, 10, 11, 12, 14, 15, 16, 18, 19, 20, 22, 23, 24, 26, 27, 28 ,30,31,32,34,35,36,38,39,40,42,43,44,46,47,48,50,51,52,54,55 ,56,58,59,60,62,63,64,66,67,68,70,71,72,74,75,76,78,79,80,82 ,83,84,86,87,88,90,91,92,94,95,96,98,99,100,102,103,104,106, 164, 165, 166 or 167, and nucleic acid sequences that encode the same amino acid sequence as the sequences shown due to the degeneracy of the genetic code.

3. The recombinant DNA molecule of claim 1 or 2, wherein the recombinant DNA molecule is operably linked to a heterologous promoter functional in a plant cell; preferably, the recombinant DNA molecule is further operably linked to a DNA molecule encoding a chloroplast transit peptide.

4. A DNA construct comprising a heterologous promoter functional in a plant cell that is operably linked to a recombinant DNA molecule as described in any one of claims 1 to 3; preferably, further comprising a DNA molecule encoding a chloroplast transit peptide that is operably linked to the recombinant DNA molecule; preferably, the DNA construct is present in the genome of a transgenic plant.

5. A plant, seed, plant tissue, plant part or cell comprising the recombinant DNA molecule of any one of claims 1 to 3, the DNA construct of claim 4, or a polypeptide encoded by the recombinant DNA molecule of claims 1 to 3; preferably, the plant, seed, plant tissue, plant part or cell comprises tolerance to at least one herbicide selected from the group consisting of: synthetic hormone herbicides, ACCase inhibitor herbicides.

6. A polypeptide having at least 98% or at least 99% identity to an amino acid sequence selected from the group consisting of SEQ ID NO: 1, 5, 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57, 61, 65, 69, 73, 77, 81, 85, 89, 93, 97, 101, 105, 109, 113, 117, 121, 125, 129, 133 or 137; preferably, the polypeptide has oxygenase activity against at least one herbicide selected from the group consisting of a synthetic hormone herbicide, an ACCase inhibitor herbicide.

7. A method for conferring herbicide tolerance to a plant, seed, cell or plant part, the method comprising expressing in the plant, seed, cell or plant part a polypeptide as claimed in claim 6; preferably, the plant, seed, cell or plant part comprises a DNA construct comprising a heterologous promoter functional in a plant cell operably linked to a recombinant DNA molecule comprising a polypeptide encoding as claimed in claim 6.

8. The method of claim 7, wherein the plant, seed, cell or plant part comprises tolerance to at least one herbicide selected from the group consisting of: synthetic hormone herbicides, ACCase inhibitor herbicides.

9. A method for producing a herbicide-tolerant transgenic plant, the method comprising transforming a plant cell or tissue with a recombinant DNA molecule as described in any one of claims 1 to 3 or a DNA construct as described in claim 4, and regenerating a herbicide-tolerant transgenic plant from the transformed plant cell or tissue; preferably, the herbicide-tolerant transgenic plant comprises tolerance to at least one herbicide selected from the group consisting of: synthetic hormone herbicides, ACCase inhibitor herbicides.

10. A method for controlling weeds in a plant growing area, the method comprising contacting a plant growing area including plants or seeds with at least one herbicide selected from the group consisting of synthetic hormone herbicides and ACCase inhibitor herbicides, the plants or seeds comprising the recombinant DNA molecule of any one of claims 1 to 3 and being tolerant to the at least one herbicide.

Citation Information

Patent Citations

  • Herbicide tolerance genes and methods of use thereof

    CN106793761A

  • Herbicide resistance proteins, gene and application

    CN114085849A

  • Herbicide tolerance genes and methods of use thereof

    CN116694654A

  • Novel herbicide resistance genes

    CN1984558A

  • Bacterial strains of delftia acidovorans MC1-r, their production and their use in the production of the r enantiomers of 2-phenoxypropionic acid derivatives

    EP1576194B1